DOJ Probes Novartis Ties With Specialty Pharmacies

Law360, New York (November 6, 2012, 6:18 PM EST) -- The U.S. Department of Justice is investigating relationships between specialty pharmacies and Novartis Pharmaceuticals Corp. regarding some of its products, including iron reduction drug Exjade, according to regulatory filings and a Novartis statement released Tuesday.

Express Scripts Inc. said Accredo Health Group, a subsidiary that offers specialty pharmacy services, had received a subpoena Oct. 1 from the U.S. Attorney for the Southern District of New York.

The subpoena requested “information from Accredo concerning its arrangements with Novartis Pharmaceuticals Corp. pertaining to the drug Exjade,” Express Scripts...
To view the full article, register now.